Miscellaneous
Use of aspirin in diabetic patients
1Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
Anatol J Cardiol 2007; (7): 5-8 PubMed ID: 18160360
Abstract
Major cardiovascular events cause about 80% of the total mortality in diabetic patients. It has been shown that diabetic patients have hyperactive platelets. It may be expected that aspirin, through its antiplatelet action, could change the risk for vascular events in people with diabetes. However, some data suggest that aspirin may be less effective than expected in preventing cardiovascular events in patients with diabetes. In this paper, we review the aspirin use in diabetics with respect to cardiovascular endpoints.
Keywords: Aspirin, diabetes mellitus, coronary artery disease
Diyabetik hastalarda aspirin
1Department of Cardiology, Faculty of Medicine, Gazi University, Ankara, Turkey
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
2Department of Cardiology, Faculty of Medicine, Gazi University, Ankara
The Anatolian Journal of Cardiology 2007; (7): 5-8 PMID: 18160360
Anahtar Kelimeler: Aspirin, diyabet, koroner arter hastalığı